Our client is a Shanghai-based investment bank specialized in cross-border transactions with a focus on healthcare and biotech. They help clients identify the best strategic partners in China and advise in licensing and financing deals.
Their key team are former research analysts and bankers in charge of China from Roth Capital and Evercore-ISI, with 25 on the ground team members performing due diligence and local communication in China for foreign clients. Over the last decade, we have built strong relationships with the top 100+ pharma and Medtech companies in China, which helped global clients...